The pathophysiology of otosclerosis: Review of current research

Hearing Research

Volumn 330, Issue , 2015, Pages 51-56

  Rudic, M ^a   Keogh, I ^a   Wagner, R ^b   Wilkinson, E ^b,c   Kiros, N ^d   Ferrary, E ^e,f   Sterkers, O ^e,f   Bozorg Grayeli, A ^e,i   Zarkovic, K ^g   Zarkovic, N ^h  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Global ENT Outreach   (United States)

^c House Ear Clinic   (United States)

^d Megbare Senayi General Hospital   (Ethiopia)

^e GH Pitié Salpêtrière Bâtiment Castaigne   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h RUDER BO KOVI INSTITUTE   (Croatia)

ⁱ UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Hearing loss; Otosclerosis; Pathophysiology; Stapes

Indexed keywords

HORMONE; ANGIOTENSIN II; COLLAGEN; HLA ANTIGEN; PARATHYROID HORMONE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNITY; CAUCASIAN; HEREDITY; HLA SYSTEM; HUMAN; INCIDENCE; INFLAMMATION; OTOSCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STAPEDOTOMY; STAPES; VIRUS; ANIMAL; GENETIC PREDISPOSITION; HEARING IMPAIRMENT; MEASLES VIRUS; METABOLISM; OXIDATIVE STRESS;

ANGIOTENSIN II; ANIMALS; AUTOIMMUNITY; COLLAGEN; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS; HLA ANTIGENS; HUMANS; INFLAMMATION; MEASLES VIRUS; OTOSCLEROSIS; OXIDATIVE STRESS; PARATHYROID HORMONE; REACTIVE OXYGEN SPECIES; STAPES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84949099552     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2015.07.014     Document Type: Review

References (72)

1. Albrecht W. Uber der verenbung der konstitutionell sporadichen taubstummheit der hereditaren labyrinthschwerhorigkeit und der otosclerose. Arch. Oh.r Nas. Kehlkopfheilk. 1922, 110:15-48.
2. Arnold W. Some remarks on the histopathology of otosclerosis. Adv. Otorhinolaryngology Basel, Krager 2007, 65:25-30. W. Arnold, R. Hausler (Eds.).
3. Arnold W., Friedmann I. Presence of viral specific antigens (measles, rubella) around the active otosclerotic focus. Ann. Otol. Rhinol. Laryngol. 1987, 66:167-171.
4. Arnold W., Niedermeyer H.P., Lehn N., Neubrt W., Hofler H. Measles virus in otosclerosis and the specific immune response of the inner ear. Acta. Otolaryngol. Stoch. 1996, 116:705-709.
5. Asaba Y., Ito M., Fumoto T., Watanabe K., Fukuhara R., Takeshita S., Nimura Y., Ishida J., Fukamizu A., Ikeda K. Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J. Bone. Min. Res. 2009, 24:241-250.
6. Aurbach G.D.S., Marx J., Spiegel A.M. Parathyroid hormone, calcitonin and the calciferols. William's Textbook of Endocrinology 1992, 1397-1453. PA Saunders, Philadelphia. J.D. Wilson, D.W. Foster (Eds.).
7. Bel Hadji Ali I., Thys M., Beltaief N., Schrauwen I., Hilgert N., Vanderstraeten K., Dieltjens N., Mnif E., Hachicha S., Besbes G., Ben Arab S., Van Camp G. A new locus for otosclerosis,OTSC8, maps to the pericentometric region of chromosome 9. Hum. Genet. 2008, 123:267-272.
8. Biasi F., Vizio B., Mascia C., Gaia E., Zarkovic N., Chiarpotto E., Leonarduzzi G., Poli G. JNK up-regulation as a key event in the pro-apoptotic interaction between TGF-b1 and 4-hydroxynonenal in colon mucosa. Free. Radic. Biol. Med. 2006, 40:443-454.
9. Bodo M., Venti G., Baroni T., Bellucci C., Giammarioli M., Donti E., Paludetti G., Stabellini G., Carinci P. Phenotype of in vitro human otosclerotic cells and its modulation by TGF beta. Cell. Mol. Biol. Noisy-le-gran) 1995, 41:1039-1049.
10. Bord S., Vedi S., Beavan S.R., Horner A., Compston J.E. Megakaryocytic population in human bone marrow increases with estrogen treatment: a role in bone remodeling?. Bone 2000, 3:397-401.
11. Boyce B.F., Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 2007, S1:98-104.
12. Browenstein Z., Goldfarb A., Levi H., Frydman M., Avraham K.B. Chromosomal mapping and phenotypic characterization of hereditary otosclerosis linked to the OTSC4 locus. Arch. Otolaryngol. Head. Neck. Surg. 2006, 132:416-424.
13. Causse J.R., Uriel J., Berges J., Shambaugh G.E., Bretlau P., Causse J.B. The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance. Am. J. Otol. 1982, 3:297-314.
14. Chen W., Campbell C.A., Green G.E., Van Den Bogaert K., Komodikis C., Manolidis L.S., Aconomou E., Kyamides Y., Christodoulou K., Faghel C., Giguére C.M., Alford R.L., Manolidis S., Van Camp G., Smith R.J. Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22-3. J. Med. Genet. 2002, 39:473-477.
15. Chen W., Meyer N.C., McKenna M.J., Pfister M., McBride D.J., Fukushima K., Thys M., Camp G.V., Smith R.J. Single-nucleotide polymorphism of the COL1A1 regulatory regions are associated with otosclerosis. Clin. Genet. 2007, 71:406-414.
16. Declau F., van Spaendonck M., Timmermans J.P., Michaels L., Liang J., Qiu J.P., van de Heyning P. Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians. Adv. Otorhinolaryngol. 2007, 67:6-16.
17. Donaldson J.A., Snyder M. Otosclerosis. Otolaryngology-head and Neck Surgery 1993, 2997-3016. Mosby-Year Book, St Louis, MI. C.W. Cummings, J.M. Frederickson, L.A. Harker, C.J. Krause, D.E. Schuller (Eds.).
18. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (edmonston strain). Cell 1993, 75:295-305.
19. Fano G., Vendidonti G., Belia S., Paludetti G., Antonica A., Donti E., Maurizi M. PTH induces modifications of transductive events in otosclerotic bone cell cultures. Cell Biochem. Funct. 1993, 11:257-261.
20. Fowler E.P. Otosclerosis in identical twins. A study of 40 pairs. Arch. Otolaryngol. 1966, 83:324-328.
21. Fraysse B., Uziel A., Anatomo-pathologie L'otospongiose Otosclerose, Rapport de la Societe Francaise d'Oto-Rhino-Laryngologie et Pathologie Cervico-Faciale 1994, 53-62. Arnette, Paris. P. Roulleau, C. Martin (Eds.).
22. Gapany-Gapanavicus B. Otosclerosis: Genetic and Surgical Rehabilitation 1975, Halsted Press, New York.
23. Gjurić M. Evolution of stapedectomy prosthesis over time. Adv. Otorhinolaryngology Basel, Krager 2007, vol. 65:174-178. W. Arnold, R. Hausler (Eds.).
24. Glasscock M.E., Shambaugh G.E.J. Diagnosis, indications for surgery, and medical therapy of otospongiosis (otosclerosis). Surgery of the Ear 1990, 370-387. PAWB Saunders, Philadelphia. M.E. Glasscock, G.E.J. Shambaugh (Eds.).
25. Grayeli A.B., Sterkers O., Roulleau P., Elbaz P., Ferrary E., Silve C. Parathyroid hormoneparathyroid hormone related peptide receptor expression and function in otosclerosis. Am. J. Physiol. 1999, 277:E10005-E11012.
26. Grayeli A.B., Palmer P., Tran Ba Huy P., Soudant J., Sterkers O., Lebon P., Ferrary E. No evidence of measles virus in stapes samples from patients with otosclerosis. J. Clin. Microbiol. 2000, 38:2655-2660.
27. Grayeli A.B., Escoubet B., Bichara M., Julien N., Silve C., Friedland G., Sterkers O., Ferrary E. Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride. Otol. Neurotol. 2003, 24:854-862.
28. Guild S.R. Histologic otosclerosis. Ann. Otol. Rhinol. Laryngol. 1944, 53:246-267.
29. Imauchi Y., Laine P., Sterkers O., Ferrary E., Grayeli A.B. Effect of 17 beta-estradiol ondiastrophic dysplasia sulfate transporter activity in otosclerotic bone cell cultures and SaOS-2 cells. Acta. Otolaryngol. 2004, 124:890-895.
30. Imauchi Y., Jeunemaitre X., Boussion M., Ferrary E., Sterkers O., Bozorg Grayeli A. Relation between renin-angiotensin-aldosterone system and otosclerosis: a genetic association and in vitro study. Otol. Neurotol. 2008, 29:295-301.
31. Janssens K., ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta 1 to the bone. Endocr. Rev. 2005, 26:743-774.
32. Kamogashira T., Fujimoto C., Yamasoba T. Reactive oxygen speies, apoptois and mitochondrial dysfunction in hearing loss. BioMed. Res. Intl. 2015, 2015:617207.
33. Karosi T., Jokay I., Konya J., Szabo L.Z., Pytel J., Szalmas A., Sziklai I. Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic stapes footplates in connection with measles virus positivity. Laryngoscope 2006, 116:1427-1433.
34. Karosi T., Szekanecz Z., Sziklai I. Otosclerosis: an autoimmune disease?. Autoimmun. Rev. 2009, 9:95-101.
35. Kennedy D.W., Hoffer M.E., Holliday M. The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol. Head. Neck Surg. 1993, 109(3 Pt 1):461-467.
36. Lamparter S., Kling L., Schrader M., Ziegler R., Pfeilschifter J. Effects of angiotensin II on bone cells in vitro. J. Cell Physiol. 1998, 175:89-98.
37. Larsson A. Otosclerosis. A genetic and clinical study. Acta. Otolaryngol. Suppl. 1960, 154:1-86.
38. Lippy W.H., Erenholz L.P., Schuring A.G., Burkey M. Does pregnancy affect otosclerosis?. Laryngoscope 2005, 115:1833-1836.
39. Magnus A. Uber verlauf and sectionsbefund eines falles von hochgradiger and eigenthumlicher gehorstorung. Arch. Ohrenheilk. 1876, 11:244-251.
40. Manasse P. Die osteitis chronica metaplastica der labyrinthkapsel 1912, JF Bergmann, Wiesbaden.
41. McKenna M.J., Mills B.G. Ultrastructural and imunohistochemical evidence of measles virus in active otosclerosis. Acta. Otolaryngol. Suppl. 1990, 470:130-139.
42. McKenna M.J., Mills B.G., Galey F.R., Linthicum F.H. Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am. J. Otol. 1986, 7(1):25-28.
43. McKenna M.J., Kristiansen A.G., Bartley M.L., Rogus J.J., Haines J.L. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am. J. Otol. 1998, 19:604-610. 179.
44. McKenna M.J., Nguyen-Huynth A.T., Kristiansen A.G. Association of otosclerosis with Sp1 binding site polymorphism in COL1A1 gene: evidence for shared genetic etiology with osteoporosis. Otol. Neurotol. 2004, 25:447-450.
45. Menger D.J., Tange R.A. The etiology of otosclerosis: a review of the literature. Clin. Otolaryngol. 2003, 28:112-120.
46. Miyazawa T., Tago C., Ueda H., Niwa H., Yanagita N. HLA associations in otosclerosis in Japanese patients. Eur. Arch. Otorhinolaryngol. 1996, 253:501-503.
47. Morrison A.W., Bundey S.E. The inheritance of otosclerosis. J. Laryngol. Otol. 1970, 84:921-932.
48. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G.E., Pamplona R., Poli G., Manuel Otin P., Riahi Y., Salvayre R., Saqsson S., Serrano J., Shamni O., Siems W., Richard R.C.M., Wiswedel I., Zarkovic K., Zarkovic N. pathological aspects of lipid peroidation. Free Radic. Res. 2010, 44:1125-1171.
49. Nibu K., Okuno T., Nomura, Matsuko K., Juji T. HLA and otosclerosis. Nippon. Jibiinkoka. Gakkai. Kaiho. 1990, 93:606-610.
50. Niedermeyer H., Arnold W., Neubert W.J., Hofler H. Evidence of measles virus RNA in otosclerotic tissue. ORL J. Otorhinolaryngol. Relat. Spec. 1994, 56:130-132.
51. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Min. Res. 1996, 11:1043-1051.
52. Quesnel A.M., Seton M., Merchant S.N., Halpin C., McKenna M.J. Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol. Neurotol. 2012, 33(8):1308-1314.
53. Roland P.S., Samy R.N. Otosclerosis. Head and Neck Surgery-otolaryngology 2006, 2126-2137. Lippincott Williams and Wilkins, Philadelphia. J. Bailey, J.T. Johnson, S.D. Newlands (Eds.).
54. Schraauwen I., Ealy M., Fransen E., Vanderstraeten K., Thys M., Meyer N.C., Cosgaera M., Huber A., Mayzzoli M., Pfister M., Smith R.J., Van Camp G. Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations. Hum. Genet. 2010, 127(2):155-162.
55. Schrauwen I., Thys M., Vanderstraeten K., Fransen E., Dieltjens N., Huyghe J.R., Ealy M., Claustres M., Cremers Cor R.W.J., Dhooge I., Declau F., Van de Heyning P., Vincent R., Somers T., Offeciers E., Smith R.J.H., Van Camp G. Association of bone morphogenetic proteins with otosclerosis. J. Bone. Min. Res. 2008, 23:507-516.
56. Schrauwen I., Thys M., Vanderstraeten K., Fransen E., Ealy M., Cremers C.W., Dhooge I., Van de Heyning P., Offeciers E., Smith R.J., Van Camp G. No evidence for association between the renin-angiotensin aldosterone system and otosclerosis in a large Belgian-Dutch population. Otol. Neurotol. 2009, 30:1079-1083.
57. Shambaugh G.E. Fenestration operation for otosclerosis. Acta. Otolaryngol. Suppl. 1994, 53:246-267.
58. Sorensen M.S., Nielsen L.P., Bretlau P., Jorgensen M.B. The role of type II collagen autoimmunity in otosclerosis revisited. Aca. Otolaryngol. 1988, 105:242-247.
59. Stankovic K.M., McKenna M.J. Current research in otosclerosis. Curr. Opin. Otolaryngol. Head. Neck. Surg. 2006, 14:347-351.
60. Sziklai I., Ribári O. Flavonoids alter bone-remodelling in auditory ossicle organ cultures. Acta Otolaryngol. 1995, 115(2):296-299.
61. Sziklai I., Batta T.J., Karosi T. Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. Eur. Arch. Otorhinolaryngol. 2009, 266:1711-1718.
62. Tato J.M., Tato J.M. Otosclerosis and races. Ann. Otol. Rhinol. Laryngol. 1967, 76:1018-1025.
63. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406:893-897.
64. Thys M., Van Den Bogaert K., Iliadou V., Vanderstraeten K., Dieltjens N., Schrauwen I., Chen W., Eleftheriades N., Grigoriadou M., Pauw R.J., Cremers C.R., Smith R.J., Petersen M.B., Van Camp G. A seventh locus for otosclerosis, OTSC7, maps to chromosome 6q13-16.1. Eur. J. Hum. Genet. 2007, 15:362-368.
65. Thys M., Schrauwen I., Vanderstraeten K., Thys M., Meyer N.C., Cosgarea M., Huber A., Mayzzoli M., Pfister M., Smith R.H., van Camp G. Detection of rare nonsynonymous variants of TGFB1 in otosclerosis patients. Ann. Hum. Genet. 2009, 73:171-175.
66. Tomek M.S., Brown M.R., Mani S.R., Ramesh A., Srisailapathy C.R., Coucke P., Zbar R.I., Bell A.M., McGuirt W.T., Fukushima K., Willems P.J., Van Camp G., Smith R.J. Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum. Mol. Genet. 1998, 7:285-290.
67. Van Den Bogaert K., Govaerts P.J., Schatteman I., Brown M.R., Caethoven G., Offeciers F.E., Somers T., Declau F., Coucke P., Van de Heyning P., Smith R.J., Van Camp G. A second gene for otosclerosis, OTSC2, maps to chromosome 7q34-36. Am. J. Hum. Genet. 2001, 68:495-500.
68. Van Den Bogaert K., Govaerts P.J., De Leenheer E.M., Schatteman I., Verstreken M., Chen W., Declau F., Cremers C.W., Van De Heyning P.H., Offeciers F.E., Somers T., Smith R.J., Van Camp G. Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 2002, 30:624-630.
69. Van Den Bogaert K., De Leenheer E.M., Chen W., Lee Y., Nürnberg P., Pennings R.J., Vanderstraeten K., Thys M., Cremers C.W., Smith R.J., Van Camp G. A fifth locus for otosclerosis, OTSC5, maps to chromosome 3q22-24. J. Med. Genet. 2004, 41:450-453.
70. Yoo T.J. Etiopathogenesis of otosclerosis: a hypothesis. Ann. Otol. Rhinol. Laryngol. 1984, 93:28-33.
71. Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol. Aspet. Med. 2003, 24:281-291.
72. Zehnder A.F., Kristiansen A.G., Adams J.C., Merchant S.N., Mc Kenna M.J. Osteoprotegerin in the inner ear may inhibit bone remodelling in the otic capsule. Laryngoscope 2005, 115:172-177.